Integra LifeSciences (IART) Tops Q1 EPS by 9c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook

Go back to Integra LifeSciences (IART) Tops Q1 EPS by 9c, Beats on Revenues; Boosts FY18 EPS/Revenue Outlook

Integra LifeSciences (IART) PT Raised to $61 at Wells Fargo

April 26, 2018 8:10 AM EDT

Wells Fargo raised its price target on Integra LifeSciences (NASDAQ: IART) to $61.00 (from $54.00) while maintaining a Market Perform rating.

... More